Oligoglycol carbonate prodrugs of 5-modified 2′-deoxyuridines: synthesis and antibacterial activity

被引：3

作者：

Negrya, Sergey D. ^{[1
]}

Jasko, Maxim V. ^{[1
]}

Makarov, Dmitriy A. ^{[1
]}

Karpenko, Inna L. ^{[1
]}

Solyev, Pavel N. ^{[1
]}

Chekhov, Vladimir O. ^{[1
]}

Efremenkova, Olga V. ^{[2
]}

Vasilieva, Byasilya F. ^{[2
]}

Efimenko, Tatiana A. ^{[2
]}

Kochetkov, Sergey N. ^{[1
]}

Alexandrova, Liudmila A. ^{[1
]}

机构：

[1] Russian Acad Sci, VA Engelhardt Inst Mol Biol, Moscow 119991, Russia

[2] GF Gause Inst New Antibiot, Moscow 119021, Russia

来源：

MENDELEEV COMMUNICATIONS | 2022年 / 32卷 / 04期

基金：

俄罗斯基础研究基金会;

关键词：

modified nucleosides; glycol carbonates; prodrugs; solubility; hydrolysis; antibacterial activity; cytotoxicity; bioavailability; INHIBITORS; NUCLEOSIDES; DESIGN;

D O I：

10.1016/j.mencom.2022.07.002

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

In order to develop a new generation of antibacterial nucleosides, a representative set of novel 3'- and 5'-tri- or tetraethylene glycol prodrug forms of 5-alkyloxymethyl-2'-deoxyuridines was synthesized. These compounds were at least two orders of magnitude more soluble than the parent nucleosides, possessed significant inhibitory activity against a set of bacteria including resistant strains of Staphylococcus aureus and Mycobacterium smegmatis, and showed low cytotoxicity. The obtained data indicate that glycol carbonates are convenient and prospective for usage in prodrugs of nucleoside derivatives with antibacterial activity.

引用

页码：433 / 435

页数：3

共 21 条

[1] Dual-targeted anti-TB/anti-HIV heterodimers
Alexandrova, Liudmila
Zicari, Sonia
Matyugina, Elena
Khandazhinskaya, Anastasia
Smirnova, Tatiana
Andreevskaya, Sofya
Chernousova, Larisa
Vanpouille, Christophe
Kochetkov, Sergei
Margolis, Leonid
[J]. ANTIVIRAL RESEARCH, 2017, 145 : 175 - 183
[2] Antiviral drugs: current state of the art
De Clercq, E
[J]. JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (01) : 73 - 89
[3] New benzophenone phosphonate derivatives
Gaman, Maxim S.
Matyugina, Elena S.
Novikov, Mikhail S.
Babkov, Denis A.
Solyev, Pavel N.
Kochetkov, Sergey N.
Khandazhinskaya, Anastasia L.
[J]. MENDELEEV COMMUNICATIONS, 2017, 27 (04) : 346 - 348
[4] Prodrugs-from Serendipity to Rational Design
Huttunen, Kristiina M.
Raunio, Hannu
Rautio, Jarkko
[J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (03) : 750 - 771
[5] Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides
Johar, M
Manning, T
Kunimoto, DY
Kumar, R
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (24) : 6663 - 6671
[6] The Prodrug Approach: A Successful Tool for Improving Drug Solubility
Jornada, Daniela Hartmann
dos Santos Fernandes, Guilherme Felipe
Chiba, Diego Eidy
Ferreira de Melo, Thais Regina
dos Santos, Jean Leandro
Chung, Man Chin
[J]. MOLECULES, 2016, 21 (01)
[7] The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain
Khandazhinskaya, A.
Yasko, M.
Shirokova, E.
[J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (24) : 2953 - 2980
[8] HIV-1 non-nucleoside reverse transcriptase inhibitors: incorporation of benzylphosphonate moiety for solubility improvement
Matyugina, Elena S.
Valuev-Elliston, Vladimir T.
Chizhov, Alexander O.
Kochetkov, Sergei N.
Khandazhinskaya, Anastasia L.
[J]. MENDELEEV COMMUNICATIONS, 2016, 26 (02) : 114 - 116
[9] New prodrugs against tuberculosis
Mori, Giorgia
Chiarelli, Laurent Roberto
Riccardi, Giovanna
Pasca, Maria Rosalia
[J]. DRUG DISCOVERY TODAY, 2017, 22 (03) : 519 - 525
[10] Negrya S D, 2021, Mol Biol (Mosk), V55, P164, DOI 10.31857/S0026898421010122

← 1 2 3 →